Cancer biologists bring in the B-cell reinforcements for immunotherapy

Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report. Cancer biologists are keenly aware of this statistic, as it drives innovations that revolutionize cancer care—innovations like immunotherapy. Immunotherapy fights cancer using the body's own immune system, often by boosting the performance of specialized adaptive immune cells called T cells.

Read it at Medical Xpress ↗

← Front page